Ryan Martins - 01 Feb 2025 Form 4 Insider Report for 89bio, Inc. (ETNB)

Signature
/s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins
Issuer symbol
ETNB
Transactions as of
01 Feb 2025
Net transactions value
-$32,045
Form type
4
Filing time
04 Feb 2025, 21:35:09 UTC
Previous filing
16 Dec 2024
Next filing
11 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Award $0 +80,000 +40% $0.000000 277,620 01 Feb 2025 Direct F1
transaction ETNB Common Stock Tax liability $32,045 -3,338 -1.2% $9.60 274,282 01 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Award $0 +300,000 $0.000000 300,000 01 Feb 2025 Common Stock 300,000 $9.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in equal semi-annual installments over three years, subject to the Reporting Person's continued service to the Issuer.
F2 These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
F3 Represents a right to purchase a total of 300,000 shares of the Issuer's Common Stock, one quarter of which will vest on February 1, 2026, with the remaining three quarters vesting in equal quarterly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.